110 related articles for article (PubMed ID: 1377741)
1. One-year follow-up on the safety and efficacy of isoprinosine for human immunodeficiency virus infection. Scandinavian Isoprinosine Study Group.
Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
J Intern Med; 1992 Jun; 231(6):607-15. PubMed ID: 1377741
[TBL] [Abstract][Full Text] [Related]
2. [Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group].
Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
Ugeskr Laeger; 1994 May; 156(22):3314-8. PubMed ID: 7520643
[TBL] [Abstract][Full Text] [Related]
3. Effect of isoprinosine on HIV antigenaemia.
Teglbjaerg LL; Kroon S; Sandström E; Moestrup T; Hansson BG; Vestergaard BF
AIDS; 1992 Feb; 6(2):199-201. PubMed ID: 1373064
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
[TBL] [Abstract][Full Text] [Related]
5. Neopterin and beta 2-microglobulin as serum markers in a placebo-controlled anti-HIV therapy trial.
Carstens J; Teglbjaerg LS; Black FT
Eur J Clin Chem Clin Biochem; 1995 Sep; 33(9):559-62. PubMed ID: 8611664
[TBL] [Abstract][Full Text] [Related]
6. [A warning against exaggerated optimism about isoprinosine in HIV infection].
Norrby R
Lakartidningen; 1990 Aug; 87(32-33):2487-8. PubMed ID: 1697923
[No Abstract] [Full Text] [Related]
7. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.
Beran J; Šalapová E; Špajdel M;
BMC Infect Dis; 2016 Nov; 16(1):648. PubMed ID: 27821093
[TBL] [Abstract][Full Text] [Related]
8. [Promising results of a Danish-Swedish clinical trial: isoprinosine administered to HIV positive patients prevented development of AIDS].
Lennholm B
Lakartidningen; 1990 Jun; 87(26-27):2253. PubMed ID: 1694549
[No Abstract] [Full Text] [Related]
9. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS.
Bekesi JG; Tsang PH; Wallace JI; Roboz JP
J Clin Lab Immunol; 1987 Dec; 24(4):155-61. PubMed ID: 2452254
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
[TBL] [Abstract][Full Text] [Related]
12. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
[TBL] [Abstract][Full Text] [Related]
13. Anti-p24 antibody reactivity in the acquired immunodeficiency syndrome (AIDS)-related complex treated with isoprinosine.
Tsang KY; Johnson EA; La Via MF
Ann Intern Med; 1988 Oct; 109(7):595. PubMed ID: 2458693
[No Abstract] [Full Text] [Related]
14. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.
Glasky AJ; Gordon JF
Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760
[TBL] [Abstract][Full Text] [Related]
15. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
Volberding PA; Lagakos SW; Grimes JM; Stein DS; Rooney J; Meng TC; Fischl MA; Collier AC; Phair JP; Hirsch MS
N Engl J Med; 1995 Aug; 333(7):401-7. PubMed ID: 7616988
[TBL] [Abstract][Full Text] [Related]
16. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
Lancet; 1994 Apr; 343(8902):871-81. PubMed ID: 7908356
[TBL] [Abstract][Full Text] [Related]
17. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
19. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.
De Simone C; Albertini F; Almaviva M; Angarano G; Chiodo F; Costigliola P; Delia S; Ferlini A; Gritti F; Mazzarello G
Med Oncol Tumor Pharmacother; 1989; 6(1):63-7. PubMed ID: 2471025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
